GlaxoSmithKline Pharmaceuticals Limited (NSE: GLAXO)

GLAXO Revenue

GlaxoSmithKline Pharmaceuticals had revenue of 10.11B INR in the quarter ending September 30, 2024, with 5.62% growth. This brings the company's revenue in the last twelve months to 35.60B, up 7.62% year-over-year. In the fiscal year ending March 31, 2024, GlaxoSmithKline Pharmaceuticals had annual revenue of 34.54B with 6.21% growth.

• Revenue (ttm): 35.60B
• Revenue Growth: +7.62%
• P/S Ratio: n/a
• Revenue / Employee: 11.09M
• Employees: 3,211
• Market Cap: 409.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	34.54B	2.02B	6.21%
Mar 31, 2023	32.52B	-263.06M	-0.80%
Mar 31, 2022	32.78B	3.52B	12.05%
Mar 31, 2021	29.26B	-2.99B	-9.27%
Mar 31, 2020	32.24B	962.62M	3.08%